About this release

This release by Public Health Scotland (PHS) summarises recent national performance, measured using the national Quality Performance Indicators relating to the diagnosis and treatment of lymphoma. The aim of the indicators is to ensure that efforts to improve treatment are focussed on improving survival and individual care experience whilst reducing variation and supporting the most effective and efficient delivery of care. The indicators for all the included cancers were developed by, and periodically undergo formal review by, Healthcare Improvement Scotland (HIS), PHS and the three regional cancer networks (NCA - North Cancer Alliance; SCAN - South East Scotland Cancer Network; and WoSCAN - West of Scotland Cancer Network). Data is gathered and recorded in a central database (eCASE electronic Cancer Audit Support Environment) by specialised cancer audit teams working in NHS Boards.

This dataset includes patients who were diagnosed with lymphoma (see full list of included anatomical sites in the PHS data definitions document) from October 2022 to September 2025.

Main points

  • The numbers of patients included in these cancer audit records increased slightly year on year:
    • 1,207 patients diagnosed between October 2022 and September 2023
    • 1,232 patients diagnosed between October 2023 and September 2024
    • 1,236 patients diagnosed between October 2024 and September 2025
  • At Scotland level for October 2024 to September 2025, the target was met for one of the 10 indicators.
  • Definitions of several indicators were amended after September 2023 following agreement through consultation. The new indicators are no longer comparable with previous years. These revised QPIs are displayed on separate rows.
  • The results illustrate that most QPI targets set have been challenging for NHS Boards to achieve and there remains room for further service improvement. Pressures on radiology departments have impacted on performance against QPIs 1, 2, 3 and 12.
  • While QPI 2 has not been met, performance against the target has improved year on year.
  • There was excellent performance throughout against the measure looking at cytogenetic testing in patients undergoing chemotherapy with curative intent (QPI 4(i)); the only indicator to be met.
  • For the latest year, three of the ten targets were only narrowly missed (QPIs 4(ii), 5 and 12(ii)) all missed by less than half a percentage gap).
  • October 2024 to September 2025 was the first year of reporting for all three specifications within QPI 12, in their current form (12i, 12ii and 12iii).

Background

The QPIs were put in place to support quality improvement in the treatment of a range of cancers - see About the QPIs. Scottish territorial health boards are required to report their performance against these nationally agreed indicators under the national cancer quality programme - see Scottish Government letter CEL 06 2012. Reporting in this current format was first undertaken in 2012. Performance for other cancers can be found in QPI reports.

Each of the networks release reports in respect of QPI performance in their region for recent years: NCA, SCAN and WoSCAN. In addition, those directly involved in service improvement can access more detailed information through the Cancer QPI Dashboard within SCRIS (Scottish Cancer Registry and Intelligence Service). Due to the level of detail, access is strictly controlled. New users may apply for authorisation via https://useraccess.nhsnss.scot.nhs.uk.

Further information

As QPI publications cover a three-year period, this publication's next release is November 2029.

General enquiries

If you have an enquiry relating to this publication, please contact Garry Hecht at phs.cancerstats@phs.scot.

Media enquiries

If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.

Requesting other formats and reporting issues

If you require publications or documents in other formats, please email phs.otherformats@phs.scot.

To report any issues with a publication, please email phs.generalpublications@phs.scot.

Older versions of this publication

Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.

Last updated: 13 November 2026